BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5457954)

  • 1. [Physical-chemical and biological properties of individual fragments of the thyrocalcitonin molecule].
    Stekol'nikov LI; Tepelina OM; Abdukarimov A; Konopatskaia VM
    Dokl Akad Nauk SSSR; 1970 May; 191(2):476-9. PubMed ID: 5457954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biphasic character of the hypocalcemic action of thyrocalcitonin].
    Stekol'nikov LI; Briskin AI; Katkovskiĭ SB; Sumarokov DD; Tepelina OM
    Biull Eksp Biol Med; 1971 Apr; 71(4):18-20. PubMed ID: 5557430
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodine determined in purified thyrocalcitonin.
    Blanquet P; Croizet M; Moura A; Dumora F; Baghdiantz A
    Science; 1967 Oct; 158(3799):381-3. PubMed ID: 6061890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and enhancement of hypocalcemic response to thyrocalcitonin in rats.
    Ogata E; Shimazawa E; Suzuki H; Yoshitoshi Y; Asano H; Ando H
    Endocrinology; 1970 Aug; 87(2):421-6. PubMed ID: 5425004
    [No Abstract]   [Full Text] [Related]  

  • 5. Human thyrocalcitonin.
    Haymovits A; Rosen JF
    Endocrinology; 1967 Nov; 81(5):993-1000. PubMed ID: 6052947
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of thyrocalcitonin in neonatal animals.
    Phillippo M; Care AD; Hinde FR
    J Endocrinol; 1969 Jan; 43(1):xv-xvi. PubMed ID: 5789236
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic human calcitonin (Cibacalcin, Ciba-Geigy): use for radioimmunoassay and bioassay.
    Raue F; Streibl W; Ziegler R
    Endokrinologie; 1982 Feb; 79(1):118-24. PubMed ID: 7084124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hypocalcemic and hypophosphatemic effects of glucagon and thyrocalcitonin.
    Aliapoulios MA; Morain WD
    Surg Forum; 1968; 19():379-80. PubMed ID: 5718672
    [No Abstract]   [Full Text] [Related]  

  • 9. An improved method for the biological assay of thyrocalcitonin.
    Cooper CW; Hirsch PF; Toverud SU; Munson PL
    Endocrinology; 1967 Sep; 81(3):610-6. PubMed ID: 6033193
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial purification of porcine and human thyrocalcitonin.
    Barrett RJ; Bell NH
    Endocrinology; 1969 Mar; 84(3):647-51. PubMed ID: 5773161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physico-chemical and biological peculiarities of thyrocalcitonin complexes with high molecular weight compounds].
    Stekol'nikov LI; Katkovskiĭ SB; Tepelina OM; Konopatskaia VM; Abdukarimov A; Egorova TV
    Vopr Med Khim; 1969; 15(3):276-9. PubMed ID: 5805161
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour growth inhibition by calcitonin: role of the age of the animal and the hypocalcemic response.
    Anghileri LJ; Delbrück H; Cressent M; Pidoux E
    Arch Geschwulstforsch; 1980; 50(7):635-9. PubMed ID: 7235863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the hypocalcemic action of thyrocalcitonin by theophylline and isoproterenol.
    Wells H; Lloyd W
    Endocrinology; 1968 Mar; 82(3):468-74. PubMed ID: 5641540
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of hog thyrocalcitonin to elicit hypocalcemia in the teleost fish, Fundulus heteroclitus.
    Pang PK; Pickford GE
    Comp Biochem Physiol; 1967 Jun; 21(3):573-8. PubMed ID: 6051657
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagon as a hypocalcemic and hypophosphatemic agent in the rat.
    Aliapoulios MA; Morain WD; Kacoyanis GP
    Gastroenterology; 1973 Dec; 65(6):912-8. PubMed ID: 4753349
    [No Abstract]   [Full Text] [Related]  

  • 16. The assay of human thyrocalcitonin in mice.
    Laljee HC; Smith RN; Dorrington KJ
    J Endocrinol; 1967 Dec; 39(4):507-16. PubMed ID: 4965435
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoassay of thyrocalcitonin. I. The method and its serological specificity.
    Tashjian AH
    Endocrinology; 1969 Jan; 84(1):140-8. PubMed ID: 4973115
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyrocalcitonin: ultracentrifugation in gradients of sucrose.
    O'Riordan JL; Tashjian AH; Munson PL; Condliffe PG; Aurbach GD
    Science; 1966 Nov; 154(3751):885-6. PubMed ID: 4304559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure and function of calcitonin.
    Stevenson JC
    Invest Cell Pathol; 1980; 3(2):187-93. PubMed ID: 6155366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the hypocalcemic effect of thyrocalcitonin by its acetylated derivative].
    Stekol'nikov LI; Ostroumova MN; Tepelina OM; Goncharenko SV; Dil'man VM
    Dokl Akad Nauk SSSR; 1971 Jan; 196(2):475-7. PubMed ID: 5573205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.